Julie Adrian

European Managing Director
inVentiv Health Communications

Check out the incredible speaker line-up to see who will be joining Julie.

Download The Latest Agenda

Day 1 – February 28, 2017

Monday, February 8th, 2016

16:40 Roundtables

1 Unlocking Full Commercial Potential by Better Integrating Clinical Development and Commercial Planning

Attendees will participate in an interactive discussion aimed at key opportunities for patient engagement in clinical and commercial strategies. Participants will discuss how the patient’s voice can be leveraged earlier in the drug development process and how this drives better health and commercial outcomes.

Irina Ringler Senior Director, Site Intelligence, Site Centricity Unit, inVentiv Health Clinical
Arno Bock, Vice President, Commercial Business Development, inVentiv Health

2 How to Engage Your Supplier Ecosystem in Anticipating and Managing Risks as You See Them

Darren Lynch, Vice President Consulting Europe, GEP

3 Partnering as a New Procurement Approach for the API Market: Broadening Market Intelligence, Improving Security of Supply and Co-Managing Risk

Dr Cristina Marti, Managing Director, Indukern Chemie AG

Day 3 – March 2, 2017

Friday, February 3rd, 2017

10:10 Smarter Integration: Unlocking the Power of Patient Engagement within Clinical and Commercial

In this session, pharmaceutical, biotech and device companies will gain insight into the value of smarter patient integration. The patient voice as a strategic driver is being included much earlier in the development process than ever before - this session will explore the ‘how’ and ‘when’ for involving patients to enhance the development and delivery of innovative therapies.

The critical shift from drug-centric to patient-relevant
Pivotal patient touchpoints throughout clinical development and launch planning that will
maximize both clinical and commercial outcomes
Positive impact of integration on efficiency and commercialization